Breaking News Instant updates and real-time market news.

KIN

Kindred Biosciences

$11.56

0.25 (2.21%)

07:06
01/14/19
01/14
07:06
01/14/19
07:06

Kindred Biosciences announces 'positive' results from study of epoCat

Kindred Biosciences announced positive topline results from its pilot field effectiveness study of epoCat (KIND-510a), a long-acting feline recombinant erythropoietin that is being developed for the management of anemia in cats. In the study, which enrolled 23 cats with anemia, epoCat rapidly increased mean hematocrit with statistically significant improvement seen as early as Week 1. The effect was sustained, with continued statistically significant improvement at Weeks 2, 3, 4, 5, and 6. Compared to baseline, the mean peak improvement in hematocrit was 55.4%. In addition, 95.5% of the 22 evaluable patients achieved treatment success over the 6-week treatment period, defined prospectively as either a 30% increase in hematocrit value over baseline or the hematocrit value reaching normal range. Furthermore, cats treated with epoCat demonstrated statistically significant improvements over baseline across all three health-related quality of life domains, Vitality, Comfort, and Emotional Wellbeing, as measured by a validated QoL instrument. Based on a preliminary review of the safety data, the drug appears to be well tolerated. The company plans to commence a pivotal study this year and is currently in discussions with the FDA regarding study design. The FDA has agreed to accept hematocrit as the primary endpoint for the pivotal study.

KIN Kindred Biosciences
$11.56

0.25 (2.21%)

08/13/18
HCWC
08/13/18
NO CHANGE
Target $16
HCWC
Buy
Kindred Biosciences price target raised to $16 from $12 at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth raised his price target for Kindred Biosciences to $16 saying the Mirataz launch is off to a good start. The analyst continues to project Mirataz revenue to reach $1.3M by the end of 2018, growing to $68M by 2027. He reiterates a Buy rating on Kindred following last week's Q2 results.
10/31/18
CANT
10/31/18
NO CHANGE
Target $25
CANT
Overweight
Kindred Biosciences price target raised to $25 from $20 at Cantor Fitzgerald
Cantor Fitzgerald analyst Brandon Folkes raised his price target for Kindred Biosciences to $25 citing the positive top-line results from the company's pilot effectiveness study of KIND-016. The analyst now has increased conviction about Kindred's antibody pipeline, which includes KIND-016, a fully caninized, high-affinity IL-31 monoclonal antibody for the treatment of atopic dermatitis in dogs, an IL4/IL13 product that is likely to readout in early 2019, and a number of undisclosed antibody products. He reiterates an Overweight rating on the shares.
11/08/18
HCWC
11/08/18
NO CHANGE
Target $19
HCWC
Buy
Kindred Biosciences price target raised to $19 from $16 at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth raised his price target for Kindred Biosciences to $19 following the company's Q3 results. The analyst sees a "strong start" for Mirataz and highlights the recent success of KIND-016 for the treatment of canine atopic dermatitis. He reiterates a Buy rating on the shares.
12/03/18
CANT
12/03/18
NO CHANGE
Target $25
CANT
Overweight
Kindred shares remain 'significantly undervalued,' says Cantor Fitzgerald
After hosting meetings with management, Cantor Fitzgerald analyst Brandon Folkes reiterates an Overweight rating on Kindred Biosciences with a $25 price target. Kindred's pipeline of novel animal health drugs will drive long-term shareholder value beyond levels currently reflected in the stock price, Folkes tells investors in a research note. He believes that the company advances its pipeline, investors should begin to appreciate the durability and peak revenue potential of the products the company brings to market. Kindred shares remain "significantly undervalued at current levels," says Folkes.

TODAY'S FREE FLY STORIES

C

Citi

$62.10

-0.08 (-0.13%)

12:50
01/17/19
01/17
12:50
01/17/19
12:50
Options
Third large call butterfly spread in the big cap banking names Thursday »

Third large call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 11

    Feb

  • 15

    Apr

  • 28

    May

  • 13

    Jul

LION

Fidelity Southern

$28.41

-0.16 (-0.56%)

12:48
01/17/19
01/17
12:48
01/17/19
12:48
Earnings
Fidelity Southern reports Q4 EPS 36c, consensus 33c »

Total assets decreased by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$49.50

0.37 (0.75%)

12:45
01/17/19
01/17
12:45
01/17/19
12:45
Options
Bristol Myers Squibb call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 28

    Jan

  • 28

    Feb

  • 18

    May

  • 20

    May

12:45
01/17/19
01/17
12:45
01/17/19
12:45
General news
Treasury's $13 B 10-year TIPS preview: the auction may suffer »

Treasury's $13 B…

FOSL

Fossil

$17.50

0.09 (0.52%)

, GOOG

Alphabet

$1,080.85

0.63 (0.06%)

12:44
01/17/19
01/17
12:44
01/17/19
12:44
Hot Stocks
Breaking Hot Stocks news story on Fossil, Alphabet, Alphabet Class A »

Fossil jumps 7.6% after…

FOSL

Fossil

$17.50

0.09 (0.52%)

GOOG

Alphabet

$1,080.85

0.63 (0.06%)

GOOGL

Alphabet Class A

$1,090.00

1.17 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 04

    Feb

  • 04

    Feb

  • 25

    Feb

  • 03

    Mar

RTN

Raytheon

$161.77

2.4 (1.51%)

12:32
01/17/19
01/17
12:32
01/17/19
12:32
Hot Stocks
Raytheon awarded $434M contract modification for SPY-6 AIM-9X tactical missiles »

Raytheon Company was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,079.92

-0.3 (-0.03%)

, FOSL

Fossil

$17.50

0.09 (0.52%)

12:31
01/17/19
01/17
12:31
01/17/19
12:31
Hot Stocks
Fossil to sell select smartwatch technology to Google for $40M »

Fossil Group (FOSL)…

GOOG

Alphabet

$1,079.92

-0.3 (-0.03%)

FOSL

Fossil

$17.50

0.09 (0.52%)

GOOGL

Alphabet Class A

$1,089.70

0.87 (0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 04

    Feb

  • 04

    Feb

  • 25

    Feb

  • 03

    Mar

JPM

JPMorgan

$102.54

0.06 (0.06%)

12:30
01/17/19
01/17
12:30
01/17/19
12:30
Options
Call butterfly in JP Morgan is similar to one in Wells Fargo »

Call butterfly in JP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

PHG

Philips

$35.40

(0.00%)

12:29
01/17/19
01/17
12:29
01/17/19
12:29
Periodicals
Philips to shutter U.K. factory as Brexit concerns intensify, Bloomberg says »

Royal Philips intends to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMFA

LM Funding

$2.19

0.765 (53.87%)

12:27
01/17/19
01/17
12:27
01/17/19
12:27
Hot Stocks
LM Funding spikes 53% after completing IIU acquisition, sees accretion in 2019 »

Earlier on Thursday, LM…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NWSA

News Corp.

$12.42

0.03 (0.24%)

12:25
01/17/19
01/17
12:25
01/17/19
12:25
Upgrade
News Corp. rating change  »

News Corp. upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDC

First Data

$22.17

0.9 (4.23%)

12:25
01/17/19
01/17
12:25
01/17/19
12:25
Options
First Data call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

BLK

BlackRock

$410.20

-2.65 (-0.64%)

12:25
01/17/19
01/17
12:25
01/17/19
12:25
Periodicals
BlackRock CEO calls on business leaders to tackle social issues, FT says »

BlackRock CEO Larry Fink…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 29

    Jan

  • 11

    Feb

MS

Morgan Stanley

$42.66

-1.82 (-4.09%)

, AAPL

Apple

$154.13

-0.75 (-0.48%)

12:22
01/17/19
01/17
12:22
01/17/19
12:22
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks opened in negative…

MS

Morgan Stanley

$42.66

-1.82 (-4.09%)

AAPL

Apple

$154.13

-0.75 (-0.48%)

JNJ

Johnson & Johnson

$128.65

0.65 (0.51%)

SHLD

Sears

$0.00

(0.00%)

SBNY

Signature Bank

$120.40

7.98 (7.10%)

MTB

M&T Bank

$161.77

7.32 (4.74%)

SIG

Signet Jewelers

$25.63

-7.745 (-23.21%)

WDC

Western Digital

$35.97

-1.83 (-4.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 22

    Jan

  • 24

    Jan

  • 27

    Jan

  • 29

    Jan

  • 07

    Feb

  • 18

    Feb

LPCN

Lipocine

$2.24

0.65 (40.88%)

12:17
01/17/19
01/17
12:17
01/17/19
12:17
Recommendations
Lipocine analyst commentary  »

Ladenburg reiterates Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
01/17/19
01/17
12:17
01/17/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMB

Limbach Holding

$5.00

(0.00%)

12:16
01/17/19
01/17
12:16
01/17/19
12:16
Hot Stocks
Limbach awarded contracts totaling $81.4M for hospital construction »

Limbach Holdings provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
01/17/19
01/17
12:16
01/17/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPCN

Lipocine

$2.27

0.68 (42.77%)

12:12
01/17/19
01/17
12:12
01/17/19
12:12
Periodicals
Lipocine NASH data contain plenty of 'red flags,' STAT's Feuerstein writes »

This morning's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVE

Cenovus Energy

$7.79

-0.19 (-2.38%)

12:10
01/17/19
01/17
12:10
01/17/19
12:10
Options
Second day of call buying in Cenovus Energy continues as shares slump »

Second day of call buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SQ

Square

$68.79

2.9 (4.40%)

12:04
01/17/19
01/17
12:04
01/17/19
12:04
Hot Stocks
Square launches free debit card for business, with sellers access to funds »

Square announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 03

    Mar

ALBO

Albireo Pharma

$24.54

0.08 (0.33%)

12:03
01/17/19
01/17
12:03
01/17/19
12:03
Hot Stocks
Albireo Pharma treatment of biliary atresia granted FDA orphan status »

Albireo Pharma's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPOR

Gulfport Energy

$8.67

-0.23 (-2.58%)

12:02
01/17/19
01/17
12:02
01/17/19
12:02
Hot Stocks
Gulfport Energy confirms receipt of Firefly letter »

Gulfport Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNFI

United Natural Foods

$13.09

-2.32 (-15.06%)

12:00
01/17/19
01/17
12:00
01/17/19
12:00
Hot Stocks
United Natural Foods falls -15.1% »

United Natural Foods is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESTE

Earthstone Energy

$5.28

-1.49 (-22.01%)

12:00
01/17/19
01/17
12:00
01/17/19
12:00
Hot Stocks
Earthstone Energy falls -21.9% »

Earthstone Energy is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.